Carvana: CVNA
Carvana is one of those "meme" stocks we read about in the financial media. It was on death's door when someone suddenly decided to buy the stock, increasing the price.…
What’s Next
The stock market had a scary fall in 2022 as interest rates rose in response to the inflation ignited by helicopter drops of money funded by the printing press. A…
Expedia: EXPE
Expedia Group reported Q2 earnings last week, and the stock sold off on the news. This article is for paid members - please login or subscribe for access.
The Week Ahead | 8/07/2023
Welcome back to “The Week Ahead,” your trusted source for insights into the ever-evolving economic landscape. As we navigate the intricate web of financial forecasts and data releases, it’s crucial…
Mattel & Barbie Fever: MAT
The retro movie is having a great deal of success. This is a big deal for the entertainment industry as they have produced dud after dud. The endless failures are…
BAIDU Update: BIDU
In October 2021, we were very bullish on Bidu. The company was growing revenue and profits rapidly, and the stock was down sharply from a peak of $360 to $169.…
Close a few Trades
When we suggest trades, we have a defined time horizon. It coincides with the expiration dates of the options we use. However, sometimes the trades meet their objective and should…
Correction on SPY Comments
On May 29, we commented that one-year options on SPY might be underpriced. This article is for registered members - please login or click here to subscribe or register for free.
Moderna: MRNA
If there is any company that reaks of SARS-COVID-19, it is Moderna. This company claims that C-19 is preventable with its mRNA gene-altering technology. The other company to use this…
The Week Ahead | 7/31/2023
There’s a saying among hikers, that “the mountains are calling, and I must go.” I took a little heed to that call, taking a respite from the hustle and bustle,…